Litcius/Paper detail

Prevalence and Risk Factors of Neurologic Manifestations in Hospitalized Children Diagnosed with Acute SARS-CoV-2 or MIS-C

Ericka L. Fink, Courtney Robertson, Mark S. Wainwright, Juan D. Roa, Marlina E. Lovett, Casey Stulce, M Yacoub, Renee M. Potera, Elizabeth Zivick, Adrian Holloway, Ashish Nagpal, Kari Wellnitz, Theresa Czech, Katelyn Even, Werther Brunow de Carvalho, Isadora Souza Rodriguez, Stephanie P. Schwartz, Tracie C. Walker, Santiago Campos-Miño, Leslie A. Dervan, Andrew S. Geneslaw, Taylor B. Sewell, Patrice Pryce, Wendy G. Silver, Jieru E. Lin, Wendy Vargas, Alexis Topjian, Alicia M. Alcamo, Jennifer L. McGuire, Jesús Domínguez-Rojas, Jaime Tasayco-Muñoz, Sue J. Hong, William J. Muller, Matthew Doerfler, Cydni N. Williams, Kurt Drury, Dhristie Bhagat, Aaron Nelson, Dana C. Price, Heda Dapul, Laura Jurema dos Santos, Robert J. Kahoud, Conall Francoeur, Brian Appavu, Kristin P. Guilliams, Shannon C. Agner, Karen Walson, Lindsey Rasmussen, Anna Janas, Peter Ferrazzano, Raquel Farias‐Moeller, Kellie Snooks, Chung‐Chou H. Chang, James Yun, Michelle E. Schober

2021Pediatric Neurology106 citationsDOIOpen Access PDF

Topics & Concepts

MedicineOdds ratioLogistic regressionConfidence intervalPediatricsIntensive care unitSevere acute respiratory syndromeEncephalopathyInternal medicineCohortCohort studySeverity of illnessSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)DiseaseInfectious disease (medical specialty)Long-Term Effects of COVID-19Kawasaki Disease and Coronary ComplicationsCOVID-19 Clinical Research Studies
Prevalence and Risk Factors of Neurologic Manifestations in Hospitalized Children Diagnosed with Acute SARS-CoV-2 or MIS-C | Litcius